In-Vitro Fertilization

In-Vitro Fertilization

Global In-Vitro Fertilization Market to Reach US$1.5 Billion by 2030

The global market for In-Vitro Fertilization estimated at US$935.9 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the analysis period. Growth in the In-Vitro Fertilization Reagents & Media segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.7 Million While China is Forecast to Grow at 11.7% CAGR

The In-Vitro Fertilization market in the U.S. is estimated at US$241.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$368.1 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global In-Vitro Fertilization Market - Key Trends & Drivers Summarized

What Is Driving the Expansion of In-Vitro Fertilization Services Worldwide?

In-vitro fertilization (IVF) has emerged as a critical solution for couples facing infertility, leading to its widespread adoption across the globe. The demand for IVF services is being propelled by various factors, including delayed childbearing due to career priorities, lifestyle changes, and the rising prevalence of fertility-related disorders. Additionally, social acceptance of assisted reproductive technologies (ART) has grown, aided by advancements in medical science and supportive government policies in several countries. With increasing awareness and access to fertility treatments, more individuals and couples are turning to IVF as a viable option for starting a family. This growth is further supported by the availability of financing options and insurance coverage in certain regions, making IVF more accessible to a broader demographic.

How Are Technological Innovations Shaping the Future of IVF?

Technological advancements are revolutionizing the IVF market, leading to higher success rates and improved patient outcomes. Innovations such as preimplantation genetic testing (PGT), time-lapse imaging, and artificial intelligence (AI)-driven embryo selection are enhancing the accuracy and efficiency of the IVF process. These technologies allow for the selection of the healthiest embryos, reducing the risk of genetic disorders and increasing the likelihood of successful pregnancies. Additionally, the development of cryopreservation techniques has enabled the storage of embryos, eggs, and sperm for extended periods, offering greater flexibility to patients. The integration of telemedicine and digital platforms is also facilitating remote consultations and monitoring, making IVF treatments more convenient and accessible, particularly in regions with limited access to fertility clinics.

Why Are Ethical and Regulatory Considerations Central to the Growth of IVF?

Ethical and regulatory considerations play a crucial role in the growth and acceptance of IVF services. Different countries have varying regulations governing the use of ART, impacting how IVF is practiced and accessed globally. For instance, some regions have restrictions on the use of donor eggs or embryos, while others may regulate the number of embryos that can be implanted or preserved. These regulations are designed to address ethical concerns related to the potential for multiple births, the use of surplus embryos, and the implications of genetic testing. As IVF technologies continue to evolve, the regulatory landscape must adapt to ensure that these advancements are used responsibly and ethically. Compliance with these regulations is essential for clinics to operate legally and maintain public trust in their services.

What Factors Are Driving Growth in the IVF Market?

The growth in the in-vitro fertilization (IVF) market is driven by several factors, including the increasing prevalence of infertility, advancements in reproductive technologies, and the expansion of fertility clinics worldwide. The rising number of women opting to delay pregnancy due to career or personal reasons has also contributed to the demand for IVF services. Additionally, societal shifts, such as the growing acceptance of same-sex couples and single parents seeking fertility treatments, have expanded the market. The availability of government support and favorable reimbursement policies in certain regions further encourages the adoption of IVF. Furthermore, technological innovations that improve success rates, such as AI in embryo selection and advanced genetic screening techniques, are propelling the market forward by offering patients better outcomes and more personalized treatment options.

 

SCOPE OF STUDY:

The report analyzes the In-Vitro Fertilization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Offering (Equipment, Reagents & Media, Accessories); End-Use (Fertility Clinics, Hospitals & Surgical Centers, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Cook Medical, Inc.
• CooperSurgical, Inc.
• EMD Serono, Inc.
• Esco Micro Pte. Ltd.
• Genea Limited
• Irvine Scientific
• Ivftech Aps
• KITAZATO CORPORATION
• Rocket Medical PLC
• The Baker Company, Inc.
• Thermo Fisher Scientific, Inc.
• Vitrolife AB

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.